275 related articles for article (PubMed ID: 20664171)
1. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3E, an exception to the rule.
Klagsbrun M; Shimizu A
J Clin Invest; 2010 Aug; 120(8):2658-60. PubMed ID: 20664165
[TBL] [Abstract][Full Text] [Related]
3. Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer.
Tseng CH; Murray KD; Jou MF; Hsu SM; Cheng HJ; Huang PH
PLoS One; 2011 Apr; 6(4):e19396. PubMed ID: 21559368
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.
Kim J; Oh WJ; Gaiano N; Yoshida Y; Gu C
Genes Dev; 2011 Jul; 25(13):1399-411. PubMed ID: 21724832
[TBL] [Abstract][Full Text] [Related]
6. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers.
Luchino J; Hocine M; Amoureux MC; Gibert B; Bernet A; Royet A; Treilleux I; Lécine P; Borg JP; Mehlen P; Chauvet S; Mann F
Cancer Cell; 2013 Nov; 24(5):673-85. PubMed ID: 24139859
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
[TBL] [Abstract][Full Text] [Related]
9. Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1.
Uesugi K; Oinuma I; Katoh H; Negishi M
J Biol Chem; 2009 Mar; 284(11):6743-51. PubMed ID: 19136556
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.
Roodink I; Kats G; van Kempen L; Grunberg M; Maass C; Verrijp K; Raats J; Leenders W
Am J Pathol; 2008 Dec; 173(6):1873-81. PubMed ID: 18974298
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.
Sakurai A; Gavard J; Annas-Linhares Y; Basile JR; Amornphimoltham P; Palmby TR; Yagi H; Zhang F; Randazzo PA; Li X; Weigert R; Gutkind JS
Mol Cell Biol; 2010 Jun; 30(12):3086-98. PubMed ID: 20385769
[TBL] [Abstract][Full Text] [Related]
12. Vascular Sema3E-Plexin-D1 Signaling Reactivation Promotes Post-stroke Recovery through VEGF Downregulation in Mice.
Yu R; Kim NS; Li Y; Jeong JY; Park SJ; Zhou B; Oh WJ
Transl Stroke Res; 2022 Feb; 13(1):142-159. PubMed ID: 33978913
[TBL] [Abstract][Full Text] [Related]
13. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
14. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys.
Watakabe A; Ohsawa S; Hashikawa T; Yamamori T
J Comp Neurol; 2006 Nov; 499(2):258-73. PubMed ID: 16977617
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum.
Ding JB; Oh WJ; Sabatini BL; Gu C
Nat Neurosci; 2011 Dec; 15(2):215-23. PubMed ID: 22179111
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.
Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E
Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K
Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291
[TBL] [Abstract][Full Text] [Related]
18. Repulsive Sema3E-Plexin-D1 signaling coordinates both axonal extension and steering via activating an autoregulatory factor, Mtss1.
Kim N; Li Y; Yu R; Kwon HS; Song A; Jun MH; Jeong JY; Lee JH; Lim HH; Kim MJ; Kim JW; Oh WJ
Elife; 2024 Mar; 13():. PubMed ID: 38526535
[TBL] [Abstract][Full Text] [Related]
19. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival.
Yong LK; Lai S; Liang Z; Poteet E; Chen F; van Buren G; Fisher W; Mo Q; Chen C; Yao Q
Oncotarget; 2016 Dec; 7(52):87431-87448. PubMed ID: 27911862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
